Population Attributable Fraction of Mortality Associated with Tobacco Smoking in Japan: A Pooled Analysis of Three Large-scale Cohort Studies

被引:111
|
作者
Katanoda, Kota [1 ,2 ]
Marugame, Tomomi [1 ,2 ]
Saika, Kumiko [1 ,2 ]
Satoh, Hiroshi [3 ]
Tajima, Kazuo [4 ]
Suzuki, Takaichiro [5 ]
Tamakoshi, Akiko [6 ]
Tsugane, Shoichiro [7 ]
Sobue, Tomotaka [1 ,2 ]
机构
[1] Natl Canc Ctr, Ctr Canc Control & Informat Serv, Canc Informat Serv, Chou Ku, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Ctr Canc Control & Informat Serv, Surveillance Div, Tokyo 1040045, Japan
[3] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan
[4] Aichi Canc Ctr, Res Inst, Nagoya, Aichi 464, Japan
[5] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Canc Control & Stat, Osaka, Japan
[6] Aichi Med Univ, Sch Med, Dept Publ Hlth, Aichi, Japan
[7] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Tokyo 1040045, Japan
关键词
Cohort Studies; Population; Risk; Smoking;
D O I
10.2188/jea.JE2007429
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Quantitative measures of the burden of tobacco smoking in Asian countries are limited. We estimated the population attributable fraction (PAF) of mortality associated with smoking in Japan, using pooled data from three large-scale cohort studies. Methods: In total, 296,836 participants (140,026 males and 156,810 females) aged 40-79 years underwent baseline surveys during the 1980s and early 1990s. The average follow-up period was 9.6 years. PAFs for all-cause mortality and individual tobacco-related diseases were estimated from smoking prevalence and relative risks. Results: The prevalence of current and former smokers was 54.4% and 25.1% for males, and 8.1% and 2.4% for females. The PAF of all-cause mortality was 27.8% [95% confidence interval (Cl): 25.2-30.4] for males and 6.7% (95% Cl: 5.9-7.5) for females. The PAF of all-cause mortality calculated by summing the disease-specific PAFs was 19.1% (95% Cl: 16.0-22.2) for males and 3.6% (95% Cl: 3.0-4.2) for females. The estimated number of deaths attributable to smoking in Japan in 2005 was 163,000 for males and 33,000 for females based oil the former set of PAFs, and 112,000 for males and 19,000 for females based oil the latter set. The leading causes of smoking-attributable deaths were cancer (61% for males and 31% for females), ischemic heart diseases and stroke (23% for males and 51% for females), and chronic obstructive pulmonary diseases and pneumonia (11% for males and 13% for females). Conclusion: The health burden due to smoking remains heavy among Japanese males. Considering the high prevalence of male current smokers and increasing prevalence of young female current smokers, effective tobacco controls and quantitative assessments of the health burden of smoking need to be continuously implemented in Japan.
引用
收藏
页码:251 / 264
页数:14
相关论文
共 34 条
  • [31] How to Ensure Inclusivity in Large-Scale General Population Cohort Studies? Lessons Learned with Regard to Including and Assessing Sex, Gender, and Sexual Orientation
    Ballering, Aranka V.
    Burke, Sarah M.
    Maeckelberghe, Els L. M.
    Rosmalen, Judith G. M.
    ARCHIVES OF SEXUAL BEHAVIOR, 2023, 52 (05) : 2163 - 2172
  • [32] Diagnosed diabetes and premature death among middle-aged Japanese: results from a large-scale population-based cohort study in Japan (JPHC study)
    Kato, Masayuki
    Noda, Mitsuhiko
    Mizoue, Tetsuya
    Goto, Atsushi
    Takahashi, Yoshihiko
    Matsushita, Yumi
    Nanri, Akiko
    Iso, Hiroyasu
    Inoue, Manami
    Sawada, Norie
    Tsugane, Shoichiro
    BMJ OPEN, 2015, 5 (04):
  • [33] Associations of serum liver enzyme levels and their changes over time with all-cause and cause-specific mortality in the general population: a large-scale national health screening cohort study
    Kim, Kyoung-Nam
    Joo, Jungmin
    Sung, Ho Kyung
    Kim, Chee Hae
    Kim, Haebin
    Kwon, Yong Jin
    BMJ OPEN, 2019, 9 (05):
  • [34] High-Negative Anti-Helicobacter pylori IgG Antibody Titers and Long-Term Risk of Gastric Cancer: Results from a Large-Scale Population-Based Cohort Study in Japan
    Inoue, Manami
    Sawada, Norie
    Goto, Atsushi
    Shimazu, Taichi
    Yamaji, Taiki
    Iwasaki, Motoki
    Tsugane, Shoichiro
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (02) : 420 - 426